These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2291662)

  • 21. Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers.
    Wenzler E; Ellis-Grosse EJ; Rodvold KA
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enoxacin absorption and elimination characteristics.
    Toothaker RD
    Clin Pharmacokinet; 1989; 16 Suppl 1():52-8. PubMed ID: 2653697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
    Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of gastric acidity on enoxacin absorption.
    Lebsack ME; Nix D; Ryerson B; Toothaker RD; Welage L; Norman AM; Schentag JJ; Sedman AJ
    Clin Pharmacol Ther; 1992 Sep; 52(3):252-6. PubMed ID: 1526081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical experience of enoxacin complicated urinary tract infection].
    Togashi M; Arakawa M; Tsubo S; Sakashita S; Maru A; Koyanagi T; Nakanishi S; Kakizaki H; Minami S; Kanagawa K
    Hinyokika Kiyo; 1988 Dec; 34(12):2233-6. PubMed ID: 3071131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue penetration and clinical efficacy of enoxacin in urinary tract infections.
    Childs SJ
    Clin Pharmacokinet; 1989; 16 Suppl 1():32-7. PubMed ID: 2653693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinolone pharmacokinetics and metabolism.
    Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter, double-blind, trimethoprim-sulfamethoxazole controlled study of enoxacin in the treatment of patients with complicated urinary tract infections.
    Cox CE; Drylie DM; Klimberg I; Childs SJ; Wegenke JD; Malek GH; Harrison LH; McCullough DL; Finegold SM; George WL
    J Urol; 1989 Mar; 141(3):575-8. PubMed ID: 2645421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical studies on enoxacin in urinary tract infection].
    Nagai N; Kaneko S; Akiyama T; Kurita T; Iguchi M; Kataoka K
    Hinyokika Kiyo; 1988 Jul; 34(7):1283-91. PubMed ID: 3051955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral bioavailability and pharmacokinetics of esculetin following intravenous and oral administration in rats.
    Kwak JH; Kim Y; Staatz CE; Baek IH
    Xenobiotica; 2021 Jul; 51(7):811-817. PubMed ID: 33949288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β₃-adrenoceptor agonist for treatment of overactive bladder.
    Eltink C; Lee J; Schaddelee M; Zhang W; Kerbusch V; Meijer J; van Marle S; Grunenberg N; Kowalski D; Drogendijk T; Moy S; Iitsuka H; van Gelderen M; Matsushima H; Sawamoto T
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):838-50. PubMed ID: 22943933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of age on the pharmacokinetics of enoxacin.
    Dobbs BR; Gazeley LR; Campbell AJ; Edwards IR
    Eur J Clin Pharmacol; 1987; 33(1):101-4. PubMed ID: 3480221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of Plasma Concentration-time Profiles of Drugs in Humans from Animals Following Oral Administration: An Allometric Approach.
    Mahmood I
    Curr Drug Metab; 2016; 17(10):1006-1013. PubMed ID: 27903219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enoxacin--a new fluoroquinolone.
    Med Lett Drugs Ther; 1992 Nov; 34(883):103-5. PubMed ID: 1435504
    [No Abstract]   [Full Text] [Related]  

  • 35. Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers.
    Martin PD; Warwick MJ; Dane AL; Brindley C; Short T
    Clin Ther; 2003 Oct; 25(10):2553-63. PubMed ID: 14667956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-dose enoxacin compared with 3-day treatment for urinary tract infection.
    Backhouse CI; Matthews JA
    Antimicrob Agents Chemother; 1989 Jun; 33(6):877-80. PubMed ID: 2764538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population Pharmacokinetics of Finafloxacin in Healthy Volunteers and Patients with Complicated Urinary Tract Infections.
    Taubert M; Lückermann M; Vente A; Dalhoff A; Fuhr U
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and absolute bioavailability of epristeride in healthy male subjects.
    Benincosa LJ; Audet PR; Lundberg D; Zariffa N; Jorkasky DK
    Biopharm Drug Dispos; 1996 Apr; 17(3):249-58. PubMed ID: 8983399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical evaluation of enoxacin].
    Zhang YY; Zhun BY; Jiang SC
    Zhonghua Nei Ke Za Zhi; 1991 Aug; 30(8):480-3, 521. PubMed ID: 1794242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.